These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19444133)
1. Atheromatous degeneration of the neointima in a bare metal stent: intravascular ultrasound evidence. Fineschi M; Carrera A; Gori T J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):572-3. PubMed ID: 19444133 [TBL] [Abstract][Full Text] [Related]
2. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731 [TBL] [Abstract][Full Text] [Related]
3. Bare metal stent thrombosis 13 years after implantation. Sarkees ML; Bavry AA; Galla JM; Bhatt DL Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857 [TBL] [Abstract][Full Text] [Related]
8. Disruption of atherosclerotic neointima as a cause of very late stent thrombosis after bare metal stent implantation. Ando H; Ishii H; Yoshikawa D; Uetani T; Amano T; Murohara T Am J Cardiol; 2012 Feb; 109(3):448-9. PubMed ID: 22071214 [TBL] [Abstract][Full Text] [Related]
9. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results. Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264 [TBL] [Abstract][Full Text] [Related]
10. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. Waksman R; Erbel R; Di Mario C; Bartunek J; de Bruyne B; Eberli FR; Erne P; Haude M; Horrigan M; Ilsley C; Böse D; Bonnier H; Koolen J; Lüscher TF; Weissman NJ; JACC Cardiovasc Interv; 2009 Apr; 2(4):312-20. PubMed ID: 19463443 [TBL] [Abstract][Full Text] [Related]
11. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582 [TBL] [Abstract][Full Text] [Related]
12. Better results with the new generation bare metal stents. Vik-Mo H Scand Cardiovasc J; 2009 Apr; 43(2):84-6. PubMed ID: 19117238 [No Abstract] [Full Text] [Related]
14. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus. Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392 [TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675 [TBL] [Abstract][Full Text] [Related]
17. Very late in-stent restenosis in a bare metal stent. Koutouzis M; Nikolidakis S; Arealis G; Kyriakides ZS Cardiology; 2007; 107(4):360-1. PubMed ID: 17283426 [TBL] [Abstract][Full Text] [Related]
18. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685 [TBL] [Abstract][Full Text] [Related]
19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
20. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus. Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]